Research Output per year
Research Output 2016 2019
2019
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand
Calzadilla-Bertot, L., Jeffrey, G. P., Jacques, B., McCaughan, G., Crawford, M., Angus, P., Jones, R., Gane, E., Munn, S., Macdonald, G., Fawcett, J., Wigg, A., Chen, J., Fink, M. & Adams, L. A., Jan 2019, In : Liver Transplantation. 25, 1, p. 25-34 10 p.Research output: Contribution to journal › Article
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Bertot, L. C. & Adams, L. A., 1 Feb 2019, In : Expert Review of Gastroenterology and Hepatology. 13, 2, p. 179-187 9 p.Research output: Contribution to journal › Review article
2018
Abide: A Novel Predictive Model of Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.
Bertot, L., Vilar-Gomez, E., Wong, V. W-S., Romero-Gomez, M., Aller-De La Fuente, R., Lai, G., Fernandez, M., Eslam, M., George, J. & Adams, L. A., Oct 2018, In : Hepatology. 68, p. 87A-87A 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract
Diabetes but Not Metabolic Syndrome Adversely Impact Survival or Liver Decompensation in Patients with Non-Alcoholic Fatty Liver Related Cirrhosis.
Bertot, L., Vilar-Gomez, E., Wong, V. W-S., Romero-Gomez, M., Aller-De La Fuente, R., Lai, G., Fernandez, M., Eslam, M., George, J. & Adams, L. A., Oct 2018, In : Hepatology. 68, p. 20A-21A 2 p.Research output: Contribution to journal › Abstract/Meeting Abstract
8
Citations
(Scopus)
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease
Bertot, L. C., Jeffrey, G. P., de Boer, B., MacQuillan, G., Garas, G., Chin, J., Huang, Y. & Adams, L. A., 1 Oct 2018, In : Liver International. 38, 10, p. 1793-1802 10 p.Research output: Contribution to journal › Article
Fibrosis
Hepatocellular Carcinoma
Liver
Liver Cirrhosis
Liver Transplantation
47
Citations
(Scopus)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., De Boer, B., McLeod, D., Hung Chan, A. W., Chalasani, N., George, J., Adams, L. A. & Romero-Gomez, M., 1 Aug 2018, In : Gastroenterology. 155, 2, p. 443-457.e17Research output: Contribution to journal › Article
Fibrosis
Cohort Studies
Mortality
Confidence Intervals
Liver
2017
11
Citations
(Scopus)
Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis
Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L., Gra-Oramas, B., Gonzalez-Fabian, L., Villa-Jimenez, O., Lazo-del Vallin, S., Diago, M., Adams, L. A., Romero-Gomez, M. & Chalasani, N., 1 Jan 2017, In : Alimentary Pharmacology and Therapeutics. 45, 2, p. 332-344 13 p.Research output: Contribution to journal › Article
Fatty Liver
Life Style
Histology
Kidney
Liver
Non-alcoholic fatty liver disease related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
Calzadilla Bertot, L., Jeffrey, G. P., Wallace, M., MacQuillan, G., Garas, G., Ching, H. L-I. & Adams, L. A., 2017, In : Hepatology Communications. 1, 1, p. 53-60Research output: Contribution to journal › Article
Open Access
Hepatocellular Carcinoma
Fibrosis
Liver Cirrhosis
Liver Diseases
Non-alcoholic Fatty Liver Disease
Non-alcoholic steatohepatitis is an important growing indication for liver transplantation in Australia and New Zealand
Bertot, L. C., Jeffrey, G. P., Delriviere, L. D., McCaughan, G., Crawford, M., Angus, P. W., Jones, R. M., Gane, E. J., Munn, S., Macdonald, G. A., Fawcett, J., Wigg, A. J., Chen, J. & Adams, L. A., Oct 2017, In : Hepatology. 66, p. 907A-908A 2 p.Research output: Contribution to journal › Abstract/Meeting Abstract
Role of Exercise in NAFLD/NASH: What is the Right Prescription?
Calzadilla Bertot, L. & Adams, L. A., 2017, In : Current Hepatology Reports. 16, 4, p. 356–365Research output: Contribution to journal › Review article
Fatty Liver
Prescriptions
Liver Diseases
Alcoholic Fatty Liver
Diet Therapy
13
Citations
(Scopus)
Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH
Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L., Gra-Oramas, B., Gonzalez-Fabian, L., Lazo-del Vallin, S., Diago, M. & Adams, L. A., 1 Dec 2017, In : Liver International. 37, 12, p. 1887-1896 10 p.Research output: Contribution to journal › Article
Liver Cirrhosis
Life Style
Fibrosis
Biomarkers
Biopsy
The Long-Term Clinical Course of Histologically Advanced Nonalcoholic Fatty Liver Disease. Impact of Fibrosis Severity on Major Clinical Outcomes.
Vilar-Gomez, E., Bertot, L. C., Wong, V. W., Fernandez, M. I. C., Aller, R., Eslam, M., George, J., Adams, L. A. & Romero-Gomez, M., Oct 2017, In : Hepatology. 66, p. 33A-34A 2 p.Research output: Contribution to journal › Abstract/Meeting Abstract
Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study.
Bertot, L. C., Gomez, E. V., Wong, V. W., Fernandez, M. C., Aller, R., Eslam, M., George, J., Romero-Gomez, M. & Adams, L. A., Oct 2017, In : Hepatology. 66, p. 1119A-1119A 1 p.Research output: Contribution to journal › Abstract/Meeting Abstract
2016
Identifying Patients With Nonalcoholic Steatohepatitis That Are Nonresponders to Therapy Reply
Vilar-Gomez, E., Calzadilla-Bertot, L., Friedman, S. L. & Romero-Gomez, M., 1 Dec 2016, In : Hepatology. 64, 6, p. 2266-2267 2 p.Research output: Contribution to journal › Letter